The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any - 3
Updated:4/2/2016
Start Date:November 2008
End Date:November 2014
Contact:Patricia Fechner, M.D.
Email:patricia.fechner@seattlechildrens.org
Phone:206-987-5037

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Gerber Pump Trial: Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Real-Time Sensor Augmentation (RTSA) in 0-3 Years Old Diabetes Patients; A One Year Randomized Controlled Clinical Trial.

The purpose of this study is to see if the use of a real-time glucose sensor improves
diabetes control in young children (less than 4 years old) with Type I diabetes when they
are initiated on insulin pump therapy.

A randomized controlled clinical trial involving patients 0-3 yrs old with type 1 diabetes.
After successful screening the subjects will be randomized into one of two groups: a CSII
group alone and a CSII group + Real Time Sensor Augmentation group (RTSA) group. The CSII
group will serve as the control for the CSII+RTSA group. The trial will last for one year.

Inclusion Criteria:

- Children less than 4 years of age with Type I diabetes for at least 3 months

Exclusion Criteria:

- Children greater than 4 years of age

- Monogenic diabetes
We found this trial at
1
site
Seattle Children's Hospital
4800 Sand Point Way NE
Seattle, Washington 98105
(206) 987-2000
Seattle Children's Hospital Seattle Children’s Hospital specializes in meeting the unique physical, emotional and developmental...
?
mi
from
Seattle, WA
Click here to add this to my saved trials